Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up

Abstract Background Zollinger-Ellison syndrome (ZES) is a rare condition characterized by hypersecretion of gastrin by gastrinoma tumors leading to severe peptic ulcer disease with potential development of gastric carcinoid tumors. Herein, we report the clinical course of a 68-year-old patient with...

Full description

Bibliographic Details
Main Authors: Lynsey M. Daniels, Marian Khalili, William F. Morano, Michaela Simoncini, Beth C. Mapow, Andrea Leaf, Wilbur B. Bowne
Format: Article
Language:English
Published: BMC 2019-12-01
Series:World Journal of Surgical Oncology
Subjects:
Zollinger-Ellison syndrome
Multiple endocrine neoplasia type 1
Octreotide
Gastrinoma
Cytoreduction
Carcinoid tumors
Online Access:https://doi.org/10.1186/s12957-019-1758-6

Internet

https://doi.org/10.1186/s12957-019-1758-6

Similar Items